Log in

NASDAQ:CYRXCryoPort Stock Price, Forecast & News

+0.11 (+0.34 %)
(As of 08/12/2020 04:00 PM ET)
Today's Range
Now: $32.53
50-Day Range
MA: $32.68
52-Week Range
Now: $32.53
Volume1.11 million shs
Average Volume544,319 shs
Market Capitalization$1.24 billion
P/E RatioN/A
Dividend YieldN/A
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
Read More
CryoPort logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.15 out of 5 stars

Industry, Sector and Symbol

Industry Freight transportation arrangement
Current SymbolNASDAQ:CYRX



Sales & Book Value

Annual Sales$33.94 million
Book Value$3.52 per share


Net Income$-18,330,000.00


Market Cap$1.24 billion
Next Earnings Date11/5/2020 (Estimated)
+0.11 (+0.34 %)
(As of 08/12/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CYRX News and Ratings via Email

Sign-up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

CryoPort (NASDAQ:CYRX) Frequently Asked Questions

How has CryoPort's stock been impacted by COVID-19?

CryoPort's stock was trading at $16.62 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CYRX shares have increased by 95.7% and is now trading at $32.53.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of CryoPort?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for CryoPort

When is CryoPort's next earnings date?

CryoPort is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for CryoPort

How were CryoPort's earnings last quarter?

CryoPort Inc (NASDAQ:CYRX) issued its quarterly earnings data on Thursday, August, 6th. The consumer goods maker reported ($0.15) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.11) by $0.04. The consumer goods maker had revenue of $9.39 million for the quarter, compared to the consensus estimate of $8.93 million. CryoPort had a negative net margin of 60.97% and a negative return on equity of 19.09%. The firm's quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.08) EPS.
View CryoPort's earnings history

What price target have analysts set for CYRX?

5 brokers have issued twelve-month price targets for CryoPort's shares. Their forecasts range from $21.00 to $40.00. On average, they anticipate CryoPort's share price to reach $29.67 in the next year. This suggests that the stock has a possible downside of 8.8%.
View analysts' price targets for CryoPort

Has CryoPort been receiving favorable news coverage?

News stories about CYRX stock have been trending extremely negative on Thursday, according to InfoTrie. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CryoPort earned a news sentiment score of -4.1 on InfoTrie's scale. They also assigned media coverage about the consumer goods maker a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near future.
View the latest news about CryoPort

Are investors shorting CryoPort?

CryoPort saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 8,800,000 shares, an increase of 14.0% from the December 31st total of 7,720,000 shares. Based on an average daily volume of 422,300 shares, the days-to-cover ratio is currently 20.8 days.
View CryoPort's Short Interest

Who are some of CryoPort's key competitors?

What other stocks do shareholders of CryoPort own?

Who are CryoPort's key executives?

CryoPort's management team includes the following people:
  • Jerrell W. Shelton, Chairman, President & Chief Executive Officer
  • Phil Wilson, SVP-Global Operations & Supply Chain
  • Robert S. Stefanovich, Chief Financial Officer, Secretary & Treasurer
  • Bret Bollinger, Chief Technology Officer
  • Mark W. Sawicki, Chief Commercial Officer

What is CryoPort's stock symbol?

CryoPort trades on the NASDAQ under the ticker symbol "CYRX."

Who are CryoPort's major shareholders?

CryoPort's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Victory Capital Management Inc. (2.68%), TimesSquare Capital Management LLC (1.99%), GW&K Investment Management LLC (1.79%), Granite Investment Partners LLC (0.99%), Columbus Circle Investors (0.78%) and Taylor Wealth Management Partners (0.63%). Company insiders that own CryoPort stock include Jerrell Shelton, Richard J Berman and Robert Stefanovich.
View institutional ownership trends for CryoPort

Which major investors are selling CryoPort stock?

CYRX stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., TimesSquare Capital Management LLC, Creative Planning, Essex Investment Management Co. LLC, Taylor Wealth Management Partners, Penbrook Management LLC, Genesee Capital Advisors LLC, and Columbus Circle Investors. Company insiders that have sold CryoPort company stock in the last year include Richard J Berman, and Robert Stefanovich.
View insider buying and selling activity for CryoPort

Which major investors are buying CryoPort stock?

CYRX stock was acquired by a variety of institutional investors in the last quarter, including Granite Investment Partners LLC, SG Americas Securities LLC, Great Lakes Advisors LLC, Bullseye Asset Management LLC, Braun Stacey Associates Inc., EAM Investors LLC, Bank of New York Mellon Corp, and New York State Common Retirement Fund.
View insider buying and selling activity for CryoPort

How do I buy shares of CryoPort?

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CryoPort's stock price today?

One share of CYRX stock can currently be purchased for approximately $32.53.

How big of a company is CryoPort?

CryoPort has a market capitalization of $1.24 billion and generates $33.94 million in revenue each year. The consumer goods maker earns $-18,330,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis.

What is CryoPort's official website?

The official website for CryoPort is www.cryoport.com.

How can I contact CryoPort?

CryoPort's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.